Cure, a prominent healthcare innovation hub located in New York City, has launched the Cure by Deerfield Middle East Health Accelerator. This new program is
Truelli, a pioneering healthtech startup, is advancing its research and development on the world’s first menstrual pad with a built-in screening technology designed to transform
New Space Connects Licensed Practitioners for Secure Collaboration, Case Discussions, and Professional Development CharmHealth, a leader in healthcare technology solutions for providers, announced the launch
The Clinical Data Intelligence platform expands its suite of AI workflows with Ask Evidently, a first-of-its-kind AI chat interface for clinicians that can be integrated
In a second late-breaking presentation, pooled data from five phase 2b and phase 3 trials of delgocitinib cream confirmed a consistent safety profile for the
The Company Will Co-Develop Custom AI Operational Assistants to Future-Proof Health Systems’ AI Capabilities and Solve Frontline Staff’s Biggest Challenges Qventus, a leading provider of
Informed by 29 studies and 15,000+ patient profiles; developed to tailor GLP-1 titration and reduce side effects. Closed Loop Medicine Ltd (CLM), a leader in
Appointment highlights Cardiosense’s growth trajectory following FDA clearance, clinical milestones, and expanded leadership team Cardiosense, a digital health company pioneering AI-enabled solutions for cardiac disease
Sai Life Sciences , an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced the opening of Unit VI, a dedicated facility for Veterinary Active Pharmaceutical Ingredient
Now supporting residents at Legacy Pointe as partnerships continue to grow Cairns Health, a healthcare technology company pioneering AI-enabled conversational companion and remote monitoring solution,
Celltrion’s biosimilar portfolio continues to grow, expanding treatment options to reach more patients in Canada Celltrion announced that Health Canada has approved Stoboclo and Osenvelt (CT-P41), biosimilars
Shanghai Henlius Biotech, Inc., and Organon announced the European Commission (EC) has granted marketing authorization for BILDYOS injection 60 mg/mL and BILPREVDA injection 120 mg/1.7
